Covid, rising infections and slow vaccinations

The contagion curve continues to rise and vaccinations are proceeding slowly throughout the country. According to the data released by the Ministry of Health, today they are registered 15.479 new positive cases (yesterday 13.762), deaths are 353 (yesterday 342). The discharged healed are 17.170, you are less than yesterday; altogether the positive cases are 382.448, 2.053 cheaper than yesterday. The swabs carried out are 279.128; the ICU patients are 2.059 while in home isolation they still remain 362.558 sobjects infected by the virus.

Based on the data from the regional monitoring and on the indications of the control room, the Minister of Health, Roberto Speranza, will soon sign a new ordinance. By virtue of the new provisions, which will go into effect from Sunday 21 February, the regions of Campania, Emilia Romagna and Molise will change from yellow to orange. Therefore, the risk of spreading the virus continues to increase and with it the strong concern of experts and the population.

Slow vaccinations

The vaccination campaign against Covid in Italy is hostage to siphoned supplies and is proceeding slowly. In fact, only a third of the expected doses in the first trimester arrived. In the last week the administrations did not meet the forecasts and only 6 over 80 out of 100 had at least one dose of the vaccine. This is highlighted by a new monitoring by the Gimbe Foundation

In the midst of so much negative news there are also comforting news about Reithera, the Italian vaccine. The news is that finally Iss e AIFA they have given the green light to phase 2 so it is hoped to conclude phase 2 and phase 3 by the summer. This, in order to start production in September; the study that has been done is on 100 million doses a year. These, in summary, are the statements of the Lazio Region Health Councilor, Alessio D'Amato, on the sidelines of an event in Tor Vergata in which the so-called "vaccine made in Italy ". There are great expectations for the Italian vaccine which would in fact solve the difficulties and delays that occurred with the purchase of foreign vaccines.